DEXTROSE 50% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextrose 50%, and when can generic versions of Dextrose 50% launch?
Dextrose 50% is a drug marketed by Hospira, Intl Medication Sys, Baxter Hlthcare, and Icu Medical Inc. and is included in six NDAs.
The generic ingredient in DEXTROSE 50% is dextrose. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for DEXTROSE 50%
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXTROSE 50% at DailyMed |
US Patents and Regulatory Information for DEXTROSE 50%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | DEXTROSE 50% | dextrose | INJECTABLE;INJECTION | 019445-001 | Jun 3, 1986 | AP | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Baxter Hlthcare | DEXTROSE 50% IN PLASTIC CONTAINER | dextrose | INJECTABLE;INJECTION | 020047-001 | Jul 2, 1991 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Intl Medication Sys | DEXTROSE 50% | dextrose | INJECTABLE;INJECTION | 203451-001 | Mar 26, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |